Conference to take place April 11-13, 2011, Grand Hyatt Hotel, Shanghai, China
WESTBOROUGH, Mass., Dec. 8, 2010 /PRNewswire-Asia/ -- IBC Life Sciences announces a partnership with BayHelix Group to co-organize the 6th Annual China Pharmaceutical R&D Summit, taking place on April 11-13, 2011 in Shanghai, China.
The BayHelix Group, an organization of leaders of Chinese heritage in the global life sciences and healthcare community, has been a strong supporter of IBC's China Pharmaceutical R&D Summit for the past five years, and the relationship between the two companies has solidified to today's co-development and co-organization of the 6th Annual event.
"IBC's goal is to be the bridge between life sciences communities on both the Eastern and Western parts of the world. We encourage individuals to explore business opportunities and develop their international networks. Our conferences help attendees share their innovative ideas for new drugs to address unmet medical needs. This fits in perfectly with BayHelix's mission and aspirations, and together, we feel we'll be able to bring the information sharing spirit and the networking opportunities to an even broader audience," explained Mimi Langley, Conference Producer, IBC Life Sciences.
"BayHelix is pleased to have the opportunity to partner with IBC for making the annual summit an even more effective setting for global R&D leaders to exchange ideas and create business opportunities. The number of life science related meetings in China has been proliferating, reflecting the tremendous growth potential in the sector. Our members at BayHelix and staff at IBC are working hard to ensure the IBC-BayHelix China Pharmaceutical R&D Summit remains as the preferred venue for people to share their experience and wisdom on the fast evolving R&D landscape in China," commented Tony Zhang, Chairman of BayHelix.
Complete conference details and registration information is available at www.IBCLifeSciences.com/china. Editorial members of the press can request a complimentary conference pass by emailing kdostie@ibcusa.com.
About IBC Life Sciences
IBC Life Sciences is the worldwide leader in scientific, technological and business conferences and courses for the life science industry. IBC Life Sciences has been supporting and supplying the life science industry with specialized information through its conferences and courses since 1987. During this time, we have developed a proud tradition of quality learning and networking events, and have established industry-leading events in two primary market sectors: Drug Discovery and Biopharmaceutical Production. For more information about IBC Life Sciences, visit www.IBCLifeSciences.com
IBC Life Sciences is a division of Informa Plc, headquartered in London. Informa is the largest publicly-owned organiser of conferences and courses in the world with an output of over 10,000 events annually. Informa publishes over 2,500 subscription-based information services including academic journals, real-time news and structured databases of commercial intelligence. Informa's book business has more than 40,000 academic and business titles in print. To learn more, visit www.Informa.com
About BayHelix Group
BayHelix (www.bayhelix.org) is a non-profit organization of business leaders of Chinese heritage in the global life sciences and healthcare community. Founded in 2001, its membership is by invitation only and currently has over 250 members throughout the United States, Canada, Europe, and Greater China. The group aspires to shape the growth of the life sciences and healthcare industry around the Pacific Rim and beyond, foster and create business opportunities, supply and nurture leaders for the community.
Press Contact:
Keri Dostie
IBC Life Sciences
Tel: +65 6508 2401
Email:kdostie@ibcusa.com
